Zygogen Provides Curis with Transgenic Zebrafish Technologyx | GenomeWeb

NEW YORK, Feb 21 – Zygogen of Atlanta, Ga. will provide Curis with its proprietary transgenic zebrafish technology for use in drug discovery, Zygogen said Wednesday.

Zebrafish are similar to knockout mice in that they can serve as model organisms for finding genome-based drug targets, but they offer the advantage of being faster to breed and less expensive.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.